Drug · DIN 02462958 · Radiopharmaceutical
CYCLODX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 4, 2020; first marketed May 1, 2017.
- Drug Identification Number (DIN)
- 02462958
- Company (DIN owner)
- Ciuss De L'estrie - Centre Hospitalier Universitaire De SherbrookeSherbrooke, Quebec, Canada
- Schedule
- Schedule C
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Fludeoxyglucose (18f) V09IX04
- Class
- Radiopharmaceutical
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLUDEOXYGLUCOSE 18F | 7.4 GBQ | ML |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “cyclodx”. A notice may cover another product or only some lots: read it to see what it covers.
- CYCLODX: Out of Specification Test ResultsNovember 6, 2025 · Radiopharmaceuticals · Product quality · Type III